Description: Our understanding of the biology of aging is increasing rapidly, creating insight into how and why any organism is aging. Some of the mechanisms by which the process of aging occurs in mammals are sufficiently well understood that clinical trials targeting them in humans to improve later life health and longevity are now being undertaken. Translating results seen in mammals to humans has the potential to increase life expectancy far beyond what we have seen historically. Come explore the current state and outlook of research.

Description: "Demographic components of Future Potential Old-Age Support Ratios – Kirill Andreev, Ph.D., United Nations, Population Division, New York, Mila Andreeva, KAMA Consulting Effect of internal Migration on the Health of Taiwan’s Elderly People – Jack C. Yue, Ph.D., – National Chengchi University, Department of Statistics, Taipei, TaiwanPopulation Aging and Canada’s Social Contract: Covid-19 Catalyst for Change – Douglas Andrews, FSA, FCIA, Ph.D., Lori J. Curtis, Ph.D., – University of Waterloo"

Description: "Establishing Methods for Annual Updates to Cohort Life Expectancies – R. Dale Hall, FSA, CERA, MAAAManaging Director of Research, Society of Actuaries Research Institute Longevity Disparity across Communities in the United States – Lijia Guo, Ph.D., ASA, MAAA , US Government Accountability Office, Applied Research and Methods Division, Washington DC"

Description: Both the SOA and AARP will showcase their recent research projects highlighting the impact of marginalization on aging and retirement. Learn how being a member of a marginalized group changes your outcomes as well as your perspective on aging and retirement.

Description: Life insurance products have evolved over time from the early mutual aid societies paying benefits when members died to comprehensive products covering a range of financial needs over an individual’s lifecycle. While some life insurance benefit riders have been offered for decades and are well-established, recent years have seen a number of accelerated benefit riders being introduced by carriers for a growing range of covered triggers. Join us as we discuss these acceleration and extended benefit riders, trends and innovations in the space, and discuss challenges and actuarial considerations in designing, pricing, and modelling them. We will also explore issues carriers have experienced, how to consider the interactions between these benefits and the underlying mortality coverage, reinsurance considerations, and more!

Description: This article provides an overview of the current Artificial Intelligence ("AI")/Machine Learning ("ML") regulatory landscape and governance considerations for insurers deploying AI/ML for their long-term care business.

Description: Description * Coinsurance has not been widely offered as a benefit reduction option to offset long-term care premium rate increases. This article uses an illustrative example to evaluate the potential impact coinsurance could have on an insurance carrier's future claim liabilities and a policyholder's premium rates. It also explores various considerations insurance carriers, regulators, and policyholders should think about when evaluating whether coinsurance is the right option.

Description: The SOA has been interested in financing of long term care for many years. As part of this interest, they approved a state-based research effort in the chosen location of Minnesota. Join authors of the research as they present their findings . The research effort looked at stakeholder responses in Minnesota to several designs that would create a state-based catastrophic long-term care insurance program. The conceptual work was based on efforts by Cohen, Feder and Favreault using the DYNASIM model created by the Urban Institute. Catastrophic coverage would be provided after a variable waiting period based on income. Private resources, including long-term care insurance, would be expected to cover the front end. (Persons on Medicaid would continue to have their gap coverage provided by that program).

Description: In this session, we will explore recent industry-wide studies focusing on mortality and policyholder behavior patterns across both Life and LTC lines of business. The Life study analyzes extensive data collected over 2018-2022, providing a unique perspective on trends heading into, during, and emerging from the pandemic. The study covers 2.5 million deaths and over 5 million voluntary surrenders and fund lapses across term and permanent life products. The LTC analysis will focus on the components of policyholder termination, with an additional perspective of total termination patterns prior to, during and post-pandemic periods. The analysis will examine cohorts of policyholders to identify the area of largest deviations from expectation and how that translated into short term results as well as where we are today. The aggregation of experience across participating companies provides insights into areas where a particular insurer’s data is not credible on its own, including: older ages, preferred/standard classes and more. At the conclusion, attendees will have an understanding of how experience emerged and considerations for setting assumptions going forward.

Description: Congress authorized the creation of the RAISE Family Caregiving Advisory Council in 2018. The Council, comprised of family caregivers and experts from a wide variety of stakeholder organizations in both the private and public sector, have been engaged in an in-depth research effort over the last two years to develop recommendations and an implementation plan to address our national caregiving crisis. This article describes their work and the newly released Report to Congress.